Consensus on the Treatment of Severe Ocular Trauma and Silicone Oil–Dependent Eyes Using Foldable Capsular Vitreous Body

Abstract

Aim: To establish evidence-based guidelines for the application of the foldable capsular vitreous body (FCVB) in managing severe ocular trauma and silicone oil–dependent eyes.

Methods: We conducted a comprehensive search across multiple databases, screening, extracting, and evaluating research evidence. Experts in ocular trauma and vitreoretinal surgery provided practical insights and formulated key questions. Using the Delphi method, the working group identified seven clinical issues and established outcome indicators. Seven recommendations were developed, reviewed, and approved by a multinational consensus expert group.

Results: This consensus presents seven evidence-based recommendations for FCVB implantation, emphasizing the importance of patient assessment, FCVB model selection, and intraoperative and postoperative management. Each recommendation is supported by detailed explanations and evidence, highlighting the potential benefits of FCVB as an alternative to traditional treatments for severe ocular trauma and silicone oil–dependent eyes, including reduced complications and improved visual outcomes.

Conclusions: On the basis of existing literature and expert consensus, this consensus provides evidence-based guidance for FCVB application in treating severe ocular trauma and silicone oil–dependent eyes. The recommendations serve as a valuable resource for ophthalmologists, facilitating more effective and safer treatment options for patients.

Keywords

consensus / evidence-based medicine / foldable capsular vitreous body (FCVB) / severe ocular trauma / silicone oil–dependent eyes

References

[1] Z. Z. Ma, “The Present Situation and Progress in the Research of the Mechanical Eye Injury in China,” [Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology 41, no. 8 (2005): 736-738.

[2] F. T. Dong, R. P. Dai, and Y. Jia, “Clinical Features of Silicone Oil Dependent Eyes,” [Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology 44, no. 11 (2008): 998-1001.

[3] F. J. Valentín-Bravo, L. García-Onrubia, C. Andrés-Iglesias, et al., “Complications Associated With the Use of Silicone Oil in Vitreoretinal Surgery: A Systemic Review and Meta-analysis,” Acta Ophthalmol 100, no. 4 (2022): e864-e880.

[4] H. Yan, K. Yang, and Z. Ma, “Guideline for the Treatment of no Light Perception Eyes Induced by Mechanical Ocular Trauma,” J Evid Based Med 15, no. 3 (2022): 302-314.

[5] Y. Liu, Z. Jiang, and Q. Gao, “Technical Standards of a Foldable Capsular Vitreous Body in Terms of Mechanical, Optical, and Biocompatible Properties,” Artificial Organs 34, no. 10 (2010): 836-845.

[6] Q. Gao, S. Mou, and J. Ge, “A New Strategy to Replace the Natural Vitreous by a Novel Capsular Artificial Vitreous Body With Pressure-control Valve,” Eye (Lond) 22, no. 3 (2008): 461-468.

[7] Q. Gao, X. Chen, and J. Ge, “Refractive Shifts in Four Selected Artificial Vitreous Substitutes Based on Gullstrand-Emsley and Liou-Brennan Schematic Eyes,” Investigative Ophthalmology & Visual Science 50, no. 7 (2009): 3529-3534.

[8] J. Chen, Q. Gao, and Y. Liu, “Clinical Device-related Article Evaluation of Morphology and Functions of a Foldable Capsular Vitreous Body in the Rabbit Eye,” Journal of Biomedical Materials Research. Part B, Applied Biomaterials 97, no. 2 (2011): 396-404.

[9] Y. Liu, Q. Ke, and J. Chen, “Sustained Mechanical Release of Dexamethasone Sodium Phosphate From a Foldable Capsular Vitreous Body,” Investigative Ophthalmology & Visual Science 51, no. 3 (2010): 1636-1642.

[10] X. Chen, Y. Liu, Z. Jiang, L. Zhou, J. Ge, and Q. Gao, “Protein Kinase Cα Downregulation via siRNA-PKCα Released From Foldable Capsular Vitreous Body in Cultured human Retinal Pigment Epithelium Cells,” Int J Nanomedicine 6 (2011): 1303-1311.

[11] Z. Jiang, T. Wang, and B. Pan, “Evaluation of the Levofloxacin Release Characters From a Rabbit Foldable Capsular Vitreous Body,” Int J Nanomedicine 7 (2012): 1-10.

[12] Z. Huang, W. Yang, and Y. Zong, “A Study of the Dexamethasone Sodium Phosphate Release Properties From a Periocular Capsular Drug Delivery System,” Drug Delivery 23, no. 3 (2016): 849-857.

[13] Z. Jiang, P. Wang, and B. Pan, “Evaluation of Levofloxacin Release Characteristics From a human Foldable Capsular Vitreous Body in Vitro,” Journal of Ocular Pharmacology and Therapeutics 28, no. 1 (2012): 33-40.

[14] T. Wang, X. Huang, and Q. Gao, “A Preliminary Study to Treat Severe Endophthalmitis via a Foldable Capsular Vitreous Body With Sustained Levofloxacin Release in Rabbits,” Investigative Ophthalmology & Visual Science 54, no. 1 (2013): 804-812.

[15] S. Mai, L. Lin, and W. Yang, “In Vitro and in Vivo Release Characteristics of Tacrolimus (FK506) From an Episcleral Drug-delivery Implant,” Journal of Ocular Pharmacology and Therapeutics 30, no. 8 (2014): 670-680.

[16] P. Wang, Q. Gao, and Z. Jiang, “Biocompatibility and Retinal Support of a Foldable Capsular Vitreous Body Injected With Saline or Silicone Oil Implanted in Rabbit Eyes,” Clin Exp Ophthalmol 40, no. 1 (2012): e67-e75.

[17] W. Yang, Y. Yuan, and Y. Zong, “Preliminary Study on Retinal Vascular and Oxygen-related Changes After Long-term Silicone Oil and Foldable Capsular Vitreous Body Tamponade,” Scientific Reports 4 (2014): 5272.

[18] S. Feng, H. Chen, and Y. Liu, “A Novel Vitreous Substitute of Using a Foldable Capsular Vitreous Body Injected With Polyvinylalcohol Hydrogel,” Scientific Reports 3 (2013): 1838.

[19] H. Chen, S. Feng, and Y. Liu, “Functional Evaluation of a Novel Vitreous Substitute Using Polyethylene Glycol Sols Injected Into a Foldable Capsular Vitreous Body,” Journal of Biomedical Materials Research. Part A 101, no. 9 (2013): 2538-2547.

[20] X. Lin, J. Ge, and Q. Gao, “Evaluation of the Flexibility, Efficacy, and Safety of a Foldable Capsular Vitreous Body in the Treatment of Severe Retinal Detachment,” Investigative Ophthalmology & Visual Science 52, no. 1 (2011): 374-381.

[21] X. Lin, Z. Wang, and Z. Jiang, “Preliminary Efficacy and Safety of a Silicone Oil-filled Foldable Capsular Vitreous Body in the Treatment of Severe Retinal Detachment,” Retina 32, no. 4 (2012): 729-741.

[22] X. Lin, X. Sun, and Z. Wang, “Three-year Efficacy and Safety of a Silicone Oil-filled Foldable-capsular-vitreous-body in Three Cases of Severe Retinal Detachment,” Transl Vis Sci Technol 5, no. 1 (2016): 2.

[23] R. Zhang, T. Wang, and C. Xie, “Evaluation of Supporting Role of a Foldable Capsular Vitreous Body With Magnetic Resonance Imaging in the Treatment of Severe Retinal Detachment in human Eyes,” Eye (Lond) 25, no. 6 (2011): 794-802.

[24] P. Wang, Q. Gao, and X. Lin, “Comprehensive Analysis of Inflammatory Immune Mediators of the Intraocular Fluid Aspirated From the Foldable Capsular Vitreous Body Filled-eyes,” PLoS ONE 7, no. 10 (2012): e46384.

[25] X. Feng, C. Li, and Q. Zheng, “Risk of Silicone Oil as Vitreous Tamponade in Pars Plana Vitrectomy: A Systematic Review and Meta-analysis,” Retina 37, no. 11 (2017): 1989-2000.

[26] Q. Y. Gao, Y. Fu, and Y. N. Hui, “Vitreous Substitutes: Challenges and Directions,” Int J Ophthalmol 8, no. 3 (2015): 437-440.

[27] Y. N. Yan, B. Tian, Q. Liu, and W. B. Wei, “Evaluation of the Efficacy and Safety of a Foldable Capsular Vitreous Body in the Treatment of Severe Retinal Detachment,” [Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology 55, no. 4 (2019): 259-266.

[28] S. Ji, M. LI, J. li, and Z. Zhang, “Clinical Application of Foldable Capsular Vitreous Body,” Chinese Journal of Ocular Trauma and Occupational Eye Disease 42, no. 11 (2020): 827-831.

[29] L. Zhang, J. Liu, S. Liu, and B. Qin, “Implantation of Foldable Capsular Vitreous Body for the Treatment of Acute Retinal Necrosis Syndrome: A Case Report. Ophthalmic surg lasers Imaging,” Retina 51, no. 11 (2020): 653-657.

[30] L. Luo, Q. Wei, Q. Liu, and Y. Wang, “Evaluation of Foldable Capsular Vitreous Body Implantation Surgery,” Int J Gen Med 15 (2022): 7077-7087.

[31] N. Liu, L. Kang, and X. Yu, “Preliminary Clinical Application of Foldable Capsular Vitreous Body in Severe Silicone Oil-dependent Eyes,” Ann Palliat Med 10, no. 10 (2021): 10922-10929.

[32] B. Zeng, Q. Wang, G. Sui, M. Wang, W. Xie, and J. Fu, “Foldable Capsular Vitreous Body Implantation for Treatment of Traumatic Retinal Detachment: Two Case Reports,” Journal of International Medical Research 49, no. 2 (2021): 300060521990257.

[33] J. Deng, H. P. Song, R. L. Zhou, T. Chen, J. Z. Wang, and Z. L. Zhu, “Evaluation of the Long-term Effect of Foldable Capsular Vitreous Bodies in Severe Ocular Rupture,” Int J Ophthalmol 14, no. 12 (2021): 1935-1940.

[34] X. Zhang, X. Tian, B. Zhang, L. Guo, X. Li, and Y. Jia, “Study on the Effectiveness and Safety of Foldable Capsular Vitreous Body Implantation,” BMC Ophthalmology [Electronic Resource] 19, no. 1 (2019): 260.

[35] Z. Zhang, S. Liu, F. Xie, B. Jiang, M. Sun, and D. Sun, “Comparison of Viscoelastic Substance Injection versus Air Filling in the Anterior Chamber During Foldable Capsular Vitreous Body (fcvb) Implant Surgery: A Prospective Randomized Controlled Trial,” Advances in Therapy 38, no. 9 (2021): 4859-4871.

[36] X. Xu, H. Ge, and J. Li, “Outcomes of a Foldable Capsular Vitreous Body Implantation: A Retrospective Study,” Disease Markers 2021 (2021): 6575195.

[37] S. Chen, M. Tian, and L. Zhang, “Reattachment After Foldable Capsular Vitreous Body Implantation in Severe Retinal Detachment Eyes,” Transl Vis Sci Technol 10, no. 11 (2021): 8.

[38] C. Zhang, R. Xiao, A. Wang, and Z. Zhao, “Silicone Oil-filled Foldable Capsular Vitreous Body versus Silicone Oil Endotamponade for Treatment of no Light Perception After Severe Ocular Trauma,” Retina 42, no. 3 (2022): 553-560.

[39] M. Li, Y. Tang, and S. Li, “Foldable Capsular Vitreous Body Implantation for Complicated Retinal Detachment Caused by Severe Ocular Trauma,” Retina 42, no. 8 (2022): 1512-1519.

[40] S. Ma, S. Zhao, C. Zhang, X. Tang, and W. Zhou, “Study on the Efficacy and Safety of Foldable Capsular Vitreous Body in the Severe Retinal Detachment Eyes,” BMC Ophthalmology [Electronic Resource] 22, no. 1 (2022): 491.

[41] S. Li, X. Wang, Z. Dou, J. Zhang, and J. Jia, “Study on Maintenance of Eyeball Morphology by Foldable Capsular Vitreous Body in Severe Ocular Trauma,” BMC Ophthalmology [Electronic Resource] 23, no. 1 (2023): 463.

[42] H. Jiang, C. Xue, Y. Gao, Y. Chen, and Y. Wang, “Clinical Application of Foldable Capsular Vitreous Bodies in the Treatment of Severe Ocular Trauma and Silicone Oil Dependent Eyes,” J Ophthalmol 2022 (2022): 3608162.

[43] Y. Y. Liu, Q. Zhang, and Y. Q. Shen, “Clinical Efficacy and Safety of Foldable Capsular Vitreous Body Implant Surgery in 22 Cases of Silicone Oil-dependent Eyes,” Curr Med Sci 43, no. 2 (2023): 393-398.

[44] C. Long, Q. Gao, and S. Liu, “Precise Prediction of Size of a Foldable Capsular Vitreous Body via Computerized Three-dimensional Ocular Reconstruction in Severe Retinal Detachment,” BMC Ophthalmology [Electronic Resource] 24, no. 1 (2024): 412.

[45] H. Lu, Y. Shen, and P. Fan, “Efficacy of Foldable Capsular Vitreous Body Implants Filled with Light or Heavy Silicone Oil in the Treatment of Silicone Oil-dependent Eyes,” Transl Vis Sci Technol 13, no. 9 (2024): 2.

[46] H. Abu Serhan, S. Irshaidat, L. Abu Serhan., and A. G. Elnahry, “Foldable Capsular Vitreous Body Indications, Complications, and Outcomes: A Systematic Review,” Graefes Archive for Clinical and Experimental Ophthalmology 261, no. 8 (2023): 2103-2116.

[47] B. J. Shea, B. C. Reeves, and G. Wells, “AMSTAR 2: A Critical Appraisal Tool for Systematic Reviews That Include Randomised or Non-randomised Studies of Healthcare Interventions, or Both,” Bmj 358 (2017): j4008.

[48] J. P. Higgins, D. G. Altman, and P. C. Gøtzsche, “The Cochrane Collaboration's Tool for Assessing Risk of Bias in Randomised Trials,” Bmj 343 (2011): d5928.

[49] P. F. Whiting, A. W. Rutjes, and M. E. Westwood, “QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies,” Annals of Internal Medicine 155, no. 8 (2011): 529-536.

[50] S. L. Norris, J. J. Meerpohl, and E. A. Akl, “The Skills and Experience of GRADE Methodologists Can be Assessed With a Simple Tool,” Journal of Clinical Epidemiology 79 (2016): 150-158. e1.

[51] R. Jaeschke, G. H. Guyatt, and P. Dellinger, “Use of GRADE Grid to Reach Decisions on Clinical Practice Guidelines When Consensus Is Elusive,” Bmj 337 (2008): a744.

[52] G. H. Guyatt, P. Alonso-Coello, and H. J. Schünemann, “Guideline Panels Should Seldom Make Good Practice Statements: Guidance From the GRADE Working Group,” Journal of Clinical Epidemiology 80 (2016): 3-7.

[53] R. Zhao, L. Lin, and J. Zeng, et al., “Development of a Rabbit Model of Persistent Hypotony Without Ciliary Body Injury,” Experimental Eye Research 190 (2020): 107858.

RIGHTS & PERMISSIONS

2025 The Author(s). Journal of Evidence-Based Medicine published by Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.